SIGMA-TAU PHARMACEUTICALS, INC.

Serial Number 73833092
Registration 1663145
710

Registration Progress

Application Filed
Oct 23, 1989
Under Examination
Approved for Publication
Nov 10, 1990
Published for Opposition
Dec 11, 1990
Registered
Nov 5, 1991

Basic Information

Serial Number
73833092
Registration Number
1663145
Filing Date
October 23, 1989
Registration Date
November 5, 1991
Published for Opposition
December 11, 1990
Renewal Date
November 5, 2011
Cancellation Date
May 20, 2022
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
710
Status Date
May 20, 2022

Rights Holder

ALFASIGMA S.P.A.

35
Address
VIA RAGAZZI DEL 99, 5
BOLOGNA BO 40133
IT

Ownership History

SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.

Original Applicant
03
00144 ROME IT

SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.

Owner at Publication
03
00144 ROME IT

SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.

Original Registrant
03
ROME IT

ALFASIGMA S.P.A.

New Owner After Registration #1
35
BOLOGNA BO IT

Legal Representation

Attorney
Michael N. Mercanti

USPTO Deadlines

Next Deadline
2310 days remaining
Section 8 & 9 (40-Year) Renewal Due (Based on registration date 1991-11-05)
Due Date
November 05, 2031
Grace Period Ends
May 05, 2032

Application History

25 events
Date Code Type Description
May 20, 2022 CAEX O CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Nov 5, 2020 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Aug 8, 2018 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 6, 2014 A7OK O AMENDMENT UNDER SECTION 7 - PROCESSED
Mar 19, 2014 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 19, 2014 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 19, 2013 MAIL I PAPER RECEIVED
Sep 19, 2013 AMD7 I SEC 7 REQUEST FILED
Dec 6, 2011 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Dec 6, 2011 RNL2 Q REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Dec 5, 2011 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 1, 2011 E89R I TEAS SECTION 8 & 9 RECEIVED
Jan 7, 2009 CFIT O CASE FILE IN TICRS
Jan 12, 2002 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jan 12, 2002 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Oct 16, 2001 89AF I REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Aug 11, 1997 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Nov 5, 1991 R.PR A REGISTERED-PRINCIPAL REGISTER
Dec 11, 1990 PUBO A PUBLISHED FOR OPPOSITION
Nov 10, 1990 NPUB O NOTICE OF PUBLICATION
Aug 30, 1990 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 9, 1990 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 16, 1990 DOCK D ASSIGNED TO EXAMINER
Jan 8, 1990 CNRT F NON-FINAL ACTION MAILED
Dec 26, 1989 DOCK D ASSIGNED TO EXAMINER

Additional Information

Other
In the statement, Column 1, line 7, ", ALZHEIMER'S DISEASE" is deleted.

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMACEUTICALS, INC."